Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 4
2006 1
2007 1
2008 1
2009 1
2011 3
2012 9
2013 10
2014 5
2015 6
2016 2
2017 4
2018 5
2019 8
2020 5
2021 4
2022 3
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units.
Lee SH, Ruan SY, Pan SC, Lee TF, Chien JY, Hsueh PR. Lee SH, et al. Among authors: pan sc. J Microbiol Immunol Infect. 2019 Dec;52(6):920-928. doi: 10.1016/j.jmii.2019.10.009. Epub 2019 Nov 23. J Microbiol Immunol Infect. 2019. PMID: 31806539 Free PMC article.
Factors associated with viral rebound among COVID-19 patients receiving oral antivirals.
Chen PY, Wang JT, Chang SY, Hung CC, Fang CT, Cheng A, Liu WD, Huang YS, Lin KY, Sun HY, Pan SC, Cheng YC, Wang HY, Sheng WH, Chen YC, Ho YL, Wu MS, Chang SC. Chen PY, et al. Among authors: pan sc. J Formos Med Assoc. 2023 Aug;122(8):766-775. doi: 10.1016/j.jfma.2023.02.008. Epub 2023 Mar 8. J Formos Med Assoc. 2023. PMID: 36934018 Free PMC article.
A Randomized Clinical Trial of 1-Dose vs Accelerated 2-Dose Schedule for Hepatitis A Virus (HAV) Revaccination Among People With Human Immunodeficiency Virus Who Were Nonresponders or Had Seroreversion After Primary HAV Vaccination.
Chen GJ, Sun HY, Lin KY, Hsieh SM, Chuang YC, Liu WD, Huang YS, Pan SC, Wu UI, Cheng A, Huang YC, Wu CH, Su YC, Liu WC, Chang SY, Hung CC. Chen GJ, et al. Among authors: pan sc. Clin Infect Dis. 2023 Aug 22;77(4):529-536. doi: 10.1093/cid/ciad206. Clin Infect Dis. 2023. PMID: 37036404 Clinical Trial.
Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial.
Estephan L, Lin YC, Lin YT, Chen YH, Pan SC, Hsieh SM, Torkehagen PF, Weng YJ, Cheng HY, Estrada JA, Waits A, Chen C, Lien CE. Estephan L, et al. Among authors: pan sc. Vaccine. 2023 May 26;41(23):3497-3505. doi: 10.1016/j.vaccine.2023.04.029. Epub 2023 Apr 12. Vaccine. 2023. PMID: 37080829 Free PMC article. Clinical Trial.
70 results